Skip to main content
OpenTrials
Completed

NCT Number: NCT01382056

Effects of Pulse Varieties on Blood Vessel Function in Peripheral Artery Disease

Consumption of a diet containing pulse crops provides flavonoid compounds that will improve vascular function and glycemic control in individuals with Peripheral Artery Disease.

Completed

Looking for future studies?

Notify Me

Key information

Age range

34 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

I.H Asper Clinical Research Institute

Winnipeg, Manitoba, R2H 2A6, Canada

About this study

This is a single site, randomized, controlled, food intervention study designed to explore the effects of pulse types and varieties on blood vessel function in individuals with Peripheral Artery Disease.

Phase One(Acute): To identify relative potency of pulse types (beans,peas, lentils,and chickpeas) for vascular activity in healthy participants and participants with Peripheral Artery Disease. Healthy participants (10) and participants with Peripheral Artery Disease (10) will be asked to consume (in random order) one test food per in-person visit over 5 visits scheduled a minimum of 6 days apart. Vascular responsiveness will be monitored non-invasively by peripheral arterial tonometry before consumption of the test food and 2 hours post food consumption. Blood samples will be collected at the same time intervals for analyses, of vascular, inflammatory, and metabolic markers as well as flavonoids present in the pulses.

Phase Two(Chronic): Chronic 8-week study using mixed beans (pinto, kidney, black, and navy) to determine improvements in vascular function, cardiovascular risk factors, and glycemic control in participants with Peripheral Artery Disease (N=75, 25/group). Participants will be randomly assigned to one of the following three groups: i) foods containing 0.6 cup mixed beans/day consumed 5 days per week (total amount is 3 cups mixed beans per week); or, ii) foods containing 0.3 cup mixed beans/day for 5 days per week); or, iii) pulse-free foods (control) consumed 5 days/week. A total of 3 in-person visits for screening, baseline and final will be required during the 8-week study schedule. Assessments of vascular function, cognitive function, food dietary intake and preferences, flavonoid levels and cardiovascular risk markers in blood and urine, glycemic control, and anthropometrics will be completed at baseline and at 8 weeks.

Phase Three(Follow-Up: An 8-week follow-up assessment with a subset of participants (n=10/group, 3 groups) with Peripheral Artery Disease will be done at 2, 4, and at 8 weeks. Assessments of vascular function, cognitive function, food dietary intake, flavonoid levels and cardiovascular risk markers in blood and urine, glycemic control, and anthropometrics will be completed. These assessments will enable us to determine the length of time the benefits of the pulse consumption are retained.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Healthy Participants, Acute Phase:

  • Healthy volunteers, male or female, >33 years of age, age matched with PAD participants ± 7 years;
  • BMI 18-30;
  • Glycated hemoglobin < 6.5%;
  • Fasting serum total cholesterol < 4 mmol/L and triglycerides < 2.5 mmol/L;
  • Blood pressure < 140/90 mm Hg;
  • Ankle-brachial Index (ABI) >0.9;
  • Willing to comply with the protocol requirements;
  • Willing to provide informed consent.

Inclusion criteria

, Participants with Peripheral Artery Disease (Acute Phase and Chronic Phase):

  • Male or female, > 40 years of age;
  • Documented Peripheral Artery Disease including those with claudication as defined by an ankle brachial Index of ≤ 0.90; or asymptomatic carotid stenosis of > 50% or confirmed by imaging; or having had a previous intervention for Peripheral Artery Disease or carotid disease;
  • Stable medication profile with no changes required for the past 3 months;
  • Willing to comply with the protocol requirements;
  • Willing to provide informed consent.

Exclusion criteria

Healthy Participants, Acute Phase:

  • Currently smoking, or smoking within the last 6 months;
  • Clinically diagnosed disease affecting the heart, liver, kidneys, lungs, gastrointestinal, endocrine or blood/immune systems that requires medical treatment;
  • Taking any prescribed medication with the exception of birth control and hormone (estrogen) replacement therapy;
  • Pregnancy;
  • Amputation of upper or lower extremity on both sides;
  • History of severe gastrointestinal reactions or allergies to pulses or ingredients used to prepare the pulse-containing and pulse-free foods.

Exclusion criteria

, Participants with Peripheral Artery Disease (Acute Phase and Chronic Phase):

  • Currently smoking, or smoking within the last 6 months;
  • Type 1 diabetes;
  • Renal failure requiring dialysis;
  • Acute cardiovascular event or medical illness within the past 3 months precluding study participation;
  • Hormone (estrogen) replacement therapy;
  • Amputation of upper or lower extremity on both sides;
  • History of severe gastrointestinal reactions or allergies to pulses or ingredients used to prepare the pulse-containing and pulse-free foods;
  • Currently participating in or having participated in a food study within the last 3 months unless randomized to a control group and consumed no study foods;
  • High pulse consumption (greater or equal to 2 servings per week);
  • Inability to adhere to a regular diet;
  • Additional intake of pulses other than the requirements outlined in the study.

Treatment and study plan

Control foods

Other

pulse-free control foods consumed daily, 5 days per week for 8 weeks

Mixed bean (higher amount)

Other

0.6 cup of mixed beans consumed 5 days per week for 8 weeks

Mixed beans (lower amount)

Other

0.3 cup of mixed beans consumed daily, 5 days per week for 5 weeks

Primary outcomes

  1. Evaluate individual pulse types and varieties in healthy participants and participants with Peripheral Artery Disease.

    Time frame: 5-week schedule

    Vascular responsiveness will be monitored non-invasively by peripheral arterial tonometry before consumption of the test food and 2 hours post food consumption. Blood samples will be collected at the same time intervals for analyses, of vascular, inflammatory, and metabolic markers as well as flavonoids present in the pulses.

Secondary outcomes

  1. Evaluate the effects of mixed beans to determine improvements in vascular function

    Time frame: 16 weeks

    Ankle brachial index, blood vessel function and claudication onset/walking distance will be measured and compared at the pre/post consumption time points (time 0, Week 8) in participants receiving food items with the most potent pulse variety or the control food items, and in follow-up during the post consumption follow-up phase at Weeks 2,4, and 8. Results of blood samples will be assessed and compared at the same time points for lipids, glucose, insulin, glycated hemoglobin and select markers of vascular function.

  2. Analysis of dietary patterns and nutritional intake, compliance and tolerability before and after consumption of an 8-week diet of mixed beans

    Time frame: 8 weeks

    Dietary patterns and nutritional intake will be assessed at baseline and at Week 8. Participants will undergo an interview to assess compliance and tolerability at various time points (weeks 2, 5, and 8) throughout the 8-week feeding schedule.

  3. Evaluate the effects of mixed beans on cognitive function

    Time frame: 16 weeks

    Data from the cognitive assessments collected at time 0 and Week 8 of the feeding schedule, and in follow-up post consumption at Weeks 2, 4, and 8, will be analyzed according to the statistical guide and recommendations provided with these tests. The cognitive tests that will be administered are: Mini Mental State Examination, Hopkins Verbal Learning, Digit Symbol Similarities Test, and Digit Span.

Sponsors and collaborators

Lead sponsor

University of Manitoba

Other

Collaborators

  • Pulse Canada

Registry information

Official study title

Effects of Pulse Varieties on Blood Vessel Function in Individuals With Peripheral Artery Disease (PAD)

Acronym: PULV-2011

Important dates

Study start
2012
Primary completion
2013
Study completion
2013
First posted
Jun 27, 2011
Registry last updated
Feb 12, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.